Related Experiment Video
Updated: Oct 7, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Dose-response relationships between urinary cobalt concentrations and obesity, insulin resistance, and
Jianwei Hu1, Jing Cao2, Qian Xu3
1Department of Group Health, Maternal and Child Health Institution, Kunshan, Jiangsu, China.
Abstract:
Excessive cobalt exposure has been shown to induce various adverse health effects in animal and human toxicity studies. However, the relationships between cobalt exposure and obesity, insulin resistance, and metabolic-related disorders are rarely studied in epidemiological studies. This study aimed to explore the dose-response relationships between urinary cobalt concentrations and obesity, insulin resistance, and metabolic-related disorders. Adult participants (≥20 years) from the 2005 to 2018 National Health and Nutrition Examination Survey were included. Restricted cubic splines and the log-binomial regression were adopted. Multivariate adjusted prevalence ratios (95% confidence intervals) comparing extreme quartiles of urinary cobalt concentrations were 1.43 (1.29-1.57) for obesity, 1.43 (1.10-1.86) for insulin resistance, 1.21 (1.09-1.34) for metabolic syndrome, 1.16 (1.10-1.23) for elevated waist circumference, 1.20 (1.09-1.33) for elevated triglycerides, 1.14 (1.01-1.29) for reduced high-density lipoprotein cholesterol (HDL-C), 1.06 (0.98-1.15) for elevated blood pressure, and 0.91 (0.79-1.06) for elevated fasting glucose, respectively. Results from the restricted cubic splines showed that an initial steep increase in risk was followed by a weaker increase in risk or a platform beyond 1.0 µg/L for obesity (prevalence ratio (95% confidence interval): 1.41 (1.29-1.55)), insulin resistance (1.33 (1.07-1.65)), metabolic syndrome (1.18 (1.11-1.31)), elevated waist circumference (1.18 (1.11-1.25)), elevated triglycerides (1.21 (1.11-1.33)), and reduced HDL-C (1.15 (1.01-1.30)), respectively. In conclusion, the prevalence of obesity, insulin resistance, metabolic syndrome, elevated waist circumference, elevated triglycerides, and reduced HDL-C progressively increased with increasing urinary cobalt concentrations. The above associations are non-linear and there is not a "safe threshold" below which there are no toxic effects of cobalt.
More Related Videos
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Drug Dosing: Obese Patients
Dose-Response Relationship: Overview
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Dose-Response Relationship: Potency and Efficacy
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant